United Therapeutics Corp. (UTHR) PT Lowered to $293 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Chris Shibutani lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $293.00 (from $302.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
